                               SEQUENCE LISTING

<110> UNIVERSITY OF IOWA RESEARCH FOUNDATION
 
<120> ANGIOTENSINS IN MUSCULAR DYSTROPHY

<130> 2009912-0093

<140> PCT/US2014/034615
<141> 2014-04-18

<150> 61/818,307
<151> 2013-05-01

<150> 61/813,929
<151> 2013-04-19

<160> 33    

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> PRT
<213> Homo sapiens

<400> 1
Asp Arg Val Tyr Ile His Pro 
1               5           


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Asp Arg Val Ser Ile His Cys 
1               5           


<210> 3
<211> 12
<212> PRT
<213> Homo sapiens

<400> 3
Asp Arg Val Tyr Ile His Pro Phe His Leu Val Ile 
1               5                   10          


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid or dicarboxylic acid 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Arg, Lys, Ala, Cit, Orn, acetylated Ser, Sar, D-Arg
      or D-Lys 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Val, Ala, Leu, Nle, Ile, Gly, Lys, Pro, HydroxyPro, Aib,
      Acpc or Tyr 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Tyr, Tyr(PO3), Thr, Ser, homoSer, azaTyr or Ala 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Ile, Ala, Leu, norLeu, Val or Gly 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> His, Arg or 6-NH2-Phe 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Cys, Pro or Ala 

<220> 
<223> see specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 4
Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5           


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<400> 5
Asp Arg Leu Tyr Ile His Pro 
1               5           


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Asp Arg Val Ser Ile His Cys 
1               5           


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid

<400> 7
Asp Arg Val Xaa Ile His Xaa 
1               5           


<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid

<400> 8
Asp Arg Leu Xaa Ile His Xaa Phe His Leu 
1               5                   10  


<210> 9
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid

<400> 9
Asp Arg Leu Xaa Ile His Xaa Phe 
1               5               


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Nle

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (3)..(6)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any cross-linked amino acid

<400> 10
Arg Leu Xaa Ile His Xaa Phe 
1               5           


<210> 11
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Nle

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (2)..(5)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any cross-linked amino acid

<400> 11
Leu Xaa Ile His Xaa Phe 
1               5       


<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid

<400> 12
Asp Arg Leu Xaa Ile His Xaa 
1               5           


<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid

<400> 13
Asp Arg Leu Xaa Ile His Xaa Phe His 
1               5                   


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any positively-charged amino acid 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any aliphatic amino acid 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid

<220>
<221> misc_feature
<222> (4)..(7)
<223> Thioether bridge between residues
 
<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any aliphatic amino acid 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid
 
<400> 14
Xaa Xaa Xaa Xaa Xaa His Xaa 
1               5           


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Abu 

<400> 15
Asp Arg Val Ala Ile His Ala 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Asp Arg Val Ala Ile His Ala 
1               5           


<210> 17
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid or absent 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any positively charged amino acid or absent

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any cross-linked amino acid
 
<220>
<221> misc_feature
<222> (4)..(7)
<223> Thioether bridge between residues

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any aliphatic amino acid 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any cross-linked amino acid
 
<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid other than Pro or absent

<220>
<221> misc_feature
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any aliphatic residue or absent

<220> 
<223> see specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 17
Xaa Xaa Leu Xaa Xaa His Xaa Xaa His Xaa 
1               5                   10  


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Abu

<400> 18
Asp Arg Leu Ala Ile His Ala 
1               5           


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<400> 19
Asp Arg Leu Ala Ile His Ala 
1               5           


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Abu

<400> 20
Asp Arg Leu Ala Ile His Ala Ile 
1               5               


<210> 21
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Nle

<400> 21
Asp Arg Leu Ala Ile His Ala Ile 
1               5               


<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<400> 22
Asp Arg Val Ser Ile His Cys 
1               5           


<210> 23
<211> 8
<212> PRT
<213> Homo sapiens

<400> 23
Asp Arg Val Tyr Ile His Pro Phe 
1               5               


<210> 24
<211> 9
<212> PRT
<213> Homo sapiens

<400> 24
Asp Arg Val Tyr Ile His Pro Phe His 
1               5                   


<210> 25
<211> 10
<212> PRT
<213> Homo sapiens

<400> 25
Asp Arg Val Tyr Ile His Pro Phe His Leu 
1               5                   10  


<210> 26
<211> 6
<212> PRT
<213> Homo sapiens

<400> 26
Arg Val Tyr Ile His Pro 
1               5       


<210> 27
<211> 7
<212> PRT
<213> Homo sapiens

<400> 27
Arg Val Tyr Ile His Pro Phe 
1               5           


<210> 28
<211> 8
<212> PRT
<213> Homo sapiens

<400> 28
Arg Val Tyr Ile His Pro Phe His 
1               5               


<210> 29
<211> 9
<212> PRT
<213> Homo sapiens

<400> 29
Arg Val Tyr Ile His Pro Phe His Leu 
1               5                   


<210> 30
<211> 6
<212> PRT
<213> Homo sapiens

<400> 30
Val Tyr Ile His Pro Phe 
1               5       


<210> 31
<211> 7
<212> PRT
<213> Homo sapiens

<400> 31
Val Tyr Ile His Pro Phe His 
1               5           


<210> 32
<211> 8
<212> PRT
<213> Homo sapiens

<400> 32
Val Tyr Ile His Pro Phe His Leu 
1               5               


<210> 33
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<221> misc_feature
<222> (4)..(7)
<223> Cross link between residues

<220> 
<223> see specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 33
Asp Arg Val Tyr Ile His Pro 
1               5           


